Add like
Add dislike
Add to saved papers

Comparative Predictors of Mortality among Patients Referred for Stress SPECT versus PET Myocardial Perfusion Imaging.

BACKGROUND: There is currently little information regarding the usage and comparative predictors of mortality among patients referred for SPECT versus PET myocardial perfusion imaging (MPI) within multimodality imaging laboratories.

METHODS: We compared the clinical characteristics and mortality outcomes among 15,718 patients referred for SPECT-MPI and 6,202 patients referred for PET-MPI between 2008-2017.

RESULTS: Approximately two-thirds of MPI studies were performed using SPECT-MPI. The PET-MPI group was substantially older and included more patients with known CAD, hypertension, diabetes, and myocardial ischemia. The annualized mortality rate was also higher in the PET-MPI group and this difference persisted after propensity matching 3,615 SPECT-MPI and 3,615 PET-MPI patients to have similar clinical profiles. Among the SPECT-MPI patients, the most potent predictor of mortality was exercise ability and performance, including consideration of patients' mode of stress testing and exercise duration. Among the PET-MPI patients, myocardial flow reserve (MFR) was the most potent predictor of mortality.

CONCLUSIONS: In our real-world setting, PET-MPI was more commonly employed among older patients with more cardiac risk factors than SPECT-MPI patients. The most potent predictors of mortality in our SPECT and PET-MPI groups were variables exclusive for each test: exercise ability/capacity for SPECT-MPI patients and MFR for PET-MPI patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app